MarketPeel
Insider Trading Intelligence
SM

Stephen Ray Mitchell

VNDA
DIRECTOR · VANDA PHARMACEUTICALS INC. · CIK 0001802653
FILING MIX · LIFETIME62%/38%
BUYS
16
SELLS
10
TOTAL VALUE
$812.4K
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
112,846
AVG SELL PX
$11.92
TRADE KIND
SHOWING 26 / 26
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Stephen Ray Mitchell, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+66.67%-0.81%-0.42%-0.39%-1.12%
14d6+16.67%+4.61%+1.01%+3.59%+3.43%
30d6+50.00%+1.70%+1.41%+0.29%+1.31%
60d6+66.67%-5.76%+4.64%-10.40%-10.79%
90d6+66.67%-6.31%+5.19%-11.50%-8.53%
180d6+66.67%-7.95%+6.01%-13.96%-23.76%
1y6+83.33%-18.70%+10.03%-28.73%-32.33%
2y6(2 pending)+100.00%-51.50%+26.23%-77.74%-75.61%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VNDA · 112,846 shares · as of Jun 4, 2026
028,21256,42384,635112,846202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 16 buys / 10 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
41,600112,846Jun 4, 2026Jun 8, 2026View →
VNDA
VANDA PHARMACEUTICALS INC.
SALEGRANT
Gift
25,83671,246May 18, 2026May 19, 2026View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
7,000$4.59$32.1K97,082Jun 13, 2025Jun 16, 2025View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
59,225104,082Jun 5, 2025Jun 9, 2025View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
5,000$5.17$25.9K44,857Nov 14, 2024Nov 18, 2024View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
37,57837,578May 17, 2024May 21, 2024View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
20,52949,857May 17, 2024May 21, 2024View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
6,500$6.05$39.3K29,328Aug 10, 2023Aug 11, 2023View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
33,96033,960Jun 8, 2023Jun 10, 2023View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
17,30735,828Jun 8, 2023Jun 10, 2023View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
24,70724,707Jun 16, 2022Jun 21, 2022View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
12,00618,521Jun 16, 2022Jun 21, 2022View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
2,700$9.48$25.6K6,515Jun 13, 2022Jun 14, 2022View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASE
5,985$10.57$63.3K15,200Sep 9, 2021Sep 13, 2021View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
13,12421,876Sep 9, 2021Sep 13, 2021View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASE
13,124$12.70$166.7K28,324Sep 9, 2021Sep 13, 2021View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
19,109$16.74$320.0K9,215Sep 9, 2021Sep 13, 2021View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
5,9850Sep 9, 2021Sep 13, 2021View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
5,000$19.42$97.1K9,215Jun 15, 2021Jun 16, 2021View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
4,0155,985Jun 15, 2021Jun 16, 2021View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASE
4,015$10.57$42.4K14,215Jun 15, 2021Jun 16, 2021View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
5,00010,200Jun 10, 2021Jun 12, 2021View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
10,00010,000Jun 10, 2021Jun 12, 2021View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
10,00010,000Jun 11, 2020Jun 15, 2020View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
5,0005,200Jun 11, 2020Jun 15, 2020View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
35,00035,000Feb 14, 2020Feb 18, 2020View →
Other insiders · VNDA
Loading peer insiders…
About this filer
CIK 0001802653
ROLE
Director
PRIMARY
VNDA
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001802653DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback